LXA4 diminishes pain in the non-compressive lumbar disc herniation model by inhibiting production of pro-inflammatory cytokines (TNF-α, and IL-1β) and upregulating IL-10 and transforming growth factor-beta (TGF-β) (38). Here, IL10 is linked to lumbar disc herniation.